Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
Isoptin 40 mg film‐coated tablets.
| Pharmaceutical Form |
|---|
|
Film‐coated tablets. Circular, biconvex, white, film‐coated tablet, embossed 40 on one side and embossed with a triangle on the other side. |
One tablet contains 40mg of Verapamil Hydrochloride.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Verapamil |
Verapamil inhibits the transmembrane influx of calcium ions into the heart and vascular smooth muscle cell. The myocardial oxygen demand is lowered directly as a result of the effect on the energy consuming metabolic processes of the myocardial cell and indirectly due to a reduction of the afterload. Due to its effect on coronary vascular smooth muscle, verapamil enhances myocardial blood flow, even in post‐stenotic areas, and relieves coronary spasms. These properties contribute to the anti‐ischaemic and antianginal efficacy of verapamil in all types of coronary artery disease. |
| List of Excipients |
|---|
|
Calcium hydrogen phosphate |
Isoptin 40mg tablets are packed in PVC blister strips in a carton.
Pack size: 100 tablets/carton.
Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
PA2010/003/001
Date of first authorization: 01 April 1980
Date of last renewal: 01 April 2010
| Drug | Countries | |
|---|---|---|
| ISOPTIN | Austria, Australia, Canada, Cyprus, Germany, Estonia, Finland, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
